Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program.
Leduc, C
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Nov 2017 - 2715-2724 p. digital
Publication Type: Journal Article
1569-8041
10.1093/annonc/mdx404 doi
Biomarkers, Tumor--genetics
Carcinoma, Non-Small-Cell Lung--drug therapy
ErbB Receptors--antagonists & inhibitors
Follow-Up Studies
France
Humans
Lung Neoplasms--drug therapy
Mutation
Prognosis
Protein Kinase Inhibitors--therapeutic use
Retrospective Studies
Survival Rate
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Nov 2017 - 2715-2724 p. digital
Publication Type: Journal Article
1569-8041
10.1093/annonc/mdx404 doi
Biomarkers, Tumor--genetics
Carcinoma, Non-Small-Cell Lung--drug therapy
ErbB Receptors--antagonists & inhibitors
Follow-Up Studies
France
Humans
Lung Neoplasms--drug therapy
Mutation
Prognosis
Protein Kinase Inhibitors--therapeutic use
Retrospective Studies
Survival Rate